# neoSurgical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/neosurgical

- Industry: Medical Devices & Equipment
- Headquarters: Dublin, Ireland
- Website: www.neosurgical.com
- Total disclosed funding: $5.5M
- Latest round: Series B (Jun 6, 2017)
- Investors on record: 1

## About

NeoSurgical Limited is a company focused on providing a premium domain name for the healthcare and surgical sectors, helping businesses establish their digital identity and enhance online visibility.Established in 2007 in Dublin, Ireland, neoSurgical Limited offers a distinctive domain name tailored for healthcare and surgical companies, enabling them to enhance their online presence. The company does not have known subsidiaries or parent companies, nor has it undergone significant pivots. The founder's history is not publicly available. In June 2017, neoSurgical Limited raised USD 5.5 mn in Series B funding from Targeted Technology, totaling USD 5.5 mn raised to date and marking the second deal for the firm.NeoSurgical.com specializes in offering a premium domain name that is currently available for sale, marketed primarily to businesses and entrepreneurs in the healthcare and surgical fields. The core offering consists of the domain itself, serving as a digital identity for companies aiming to establish an online presence related to surgical innovations, medical technologies, or healthcare services. Potential customers include medical device manufacturers, surgical practices, healthcare consultants, and digital health platforms looking to enhance their branding and visibility in a competitive market across North America, Europe, and Asia.The revenue model for neoSurgical.com is centered around the direct sale of the domain, priced at USD 6,095, with an option for a financing plan of USD 507.92 per month over 12 months. Transactions typically occur through a straightforward purchasing process, allowing clients flexibility in financial commitment. This model primarily serves B2B clients seeking a robust online presence, with no additional services bundled with the domain, ensuring focused revenue generation from domain sales alone.Following the Series B funding round in June 2017, neoSurgical Limited plans to leverage the raised USD 5.5 mn to enhance market reach and product offerings. The company is currently in the process of developing additional digital assets aimed at further penetrating the healthcare sector. Specific geographic expansion is being targeted in emerging markets across Asia and Europe, with plans to launch new products by the end of 2024.

## Funding rounds

- Series B, Jun 6, 2017, $5.5M — Targeted Technology

## Investors

- Targeted Technology (https://capitalatlas.ai/funds/targeted-technology) — Series B